On 29 October 2007, orphan designation (EU/3/07/490) was granted by the European Commission to Bone Therapeutics SA, Belgium, for human autologous bone-forming cells derived from bone marrow stem cells for treatment of non-traumatic osteonecrosis.
Please note that this product was withdrawn from the Union Register of orphan medicinal products in November 2019 on request of the Sponsor.
Human autologous bone-forming cells derived from bone marrow stem cells
|Disease / condition||
Treatment of non-traumatic osteonecrosis
|Date of first decision||
|EU designation number||
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.